Vitamin D, selenium, and antidiabetic drugs in the treatment of type 2 diabetes mellitus with Hashimoto's thyroiditis

Table 4 Comparison of blood glucose index and blood lipid index pre-treatment, 3 months after treatment, and 6 months after treatment in 3 groups

Group	LDL-C (pmol/L)			FBG(pmol/L)			HbA1c(%)
	Pre-treatment	After 3 months of treatment	After 6 months of treatment	Pre-treatment	After 3 months of treatment	After 6 months of treatment	Pre-treatment	After 3 months of treatment	After 6 months of treatment
Control group (n = 50)	1.31 ± 0.43	1.43 ± 0.44	1.48 ± 0.45	13.52 ± 3.35	13.46 ± 3.33	13.37 ± 3.28	9.16 ± 1.55	8.90 ± 1.35	7.65 ± 1.26
Test group A (n = 50)	1.34 ± 0.43	1.76 ± 0.46a	2.18 ± 0.50a	13.69 ± 3.76	12.34 ± 3.82a	12.98 ± 2.98a	8.98 ± 1.58	8.55 ± 1.30	7.09 ± 1.15a,b
Test group B (n = 50)	1.33 ± 0.40	1.87 ± 0.48a	2.41 ± 0.58a,b	13.60 ± 3.80	9.64 ± 1.45a	7.30 ± 1.48a,b	9.35 ± 1.52	8.20 ± 1.2a	6.45 ± 1.10a,b
F value	0.067	11.717	44.330	0.031	20.859	49.495	0.712	3.603	13.130
P value	0.935	< 0.001	< 0.001	0.970	< 0.001	< 0.001	0.492	0.030	< 0.001

^aP < 0.05 vs group pre-treatment.

^bP < 0.05 vs 3 months after treatment.

LDL-C: Low-density lipoprotein cholesterol; FBG: Fasting blood glucose; HbA1c: Hemoglobin A1c.